Clinical Trial Information Request for Protocol 23-695 Title Phase 2, randomized, trial of maintenance Letrozole/Abemaciclib vs Pembrolizumab after systemic therapy in patients with advanced or recurrent estrogen receptor positive, mismatch repair proficient, TP53 wild-type endometrial cancer PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone